Lanthionine synthetase C-like protein 1 (LanCL1): a therapeutic target for neuropathic pain
Listen to this summary
The authors investigate the role of lanthionine synthetase C-like protein 1 (LanCL1) in chronic neuropathic pain, seeking to determine its potential as a therapeutic target. They demonstrate that the novel peptide ligand LAT8881 effectively reverses mechanical allodynia in rodent models of neuropathic pain by modulating LanCL1 activity, highlighting its critical role in neuropathic hypersensitivity. The study suggests that targeting LanCL1 could offer new avenues for treating neuropathic pain.
This is one of 33,000+ journals available on OSLR. Try it free for 14 days.
Free 14-day trial. 33,000+ journals. Cancel anytime.
More from Pain
View all →More in Anesthesiology
View all →Jun 24, 2026 · Journal of addiction medicine
Trends in Public Opinion About US Illicit Drug Policy: Results From the 2000 to 2025 Gallup Survey
Jun 24, 2026 · Journal of addiction medicine
Implementation of Dyadic Care to Support Clinical, Administrative, and Service Wraparound Needs for the Opioid-Exposed Mother and Infant
Jun 24, 2026 · Critical care medicine
Ethical Implications of the Slow Code: A Systematic Review of Ethics of Slow Codes in U.S. Hospitals
Jun 24, 2026 · Lancet (London, England)
Safety, pharmacokinetics, and exploratory efficacy of the oral ghrelin receptor agonist AC01 in heart failure with reduced ejection fraction (GOAL-HF1): a randomised, double-blind, placebo-controlled, phase 1b/2a study
Jun 24, 2026 · Journal of addiction medicine
Medicaid Prior Authorization and Discontinuation of Buprenorphine
Jun 24, 2026 · The New England journal of medicine
Ten-Year Outcomes after CAR T-Cell Therapy for B-Cell Lymphomas
"Oslr has become part of my weekly routine on my day off. The clinical relevance of the summaries is outstanding — I'd rate it 9/10. Being able to consume research hands-free is a huge advantage for busy physicians."
Dr. Jennifer Thompson
Portland, OR
Stay current without falling behind
33,000+ journals. 3-minute audio summaries. Free for 14 days.
